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Background
DNA vaccine is one of the most promising strategies for
development of an efficacious HIV vaccine. Current HIV
DNA vaccines induce potent immune responses (IR) in
rodents but their immunogenicity remains weak in
human and non-human primates (NHP). On the other
hand, the MRKAd-5 based HIV vaccine that induces strong
HIV-specific T cell responses failed to control HIV infec-
tion in human clinical trial. Therefore, strategies that
enhance the immunogenicity of HIV DNA vaccines
together with a strong commitment to better characterize
the vaccine-induced IR are needed. Such comprehensive
studies are critical in defining correlates of immune pro-
tection.
Methods
Accordingly, we used a single high dose of our
Δ4SHIVKU2 DNA vaccine to immunize 5 Rhesus mon-
keys and performed a longitudinal analysis of induced IR
using multiparametric flow cytometry based assays.
Results
All 5 macaques developed long-lasting, potent T cell
immune responses in their peripheral blood cells
(PBMC). Interestingly, a peak of primary response was
observed during the 4 weeks post-immunization. Then
the response underwent a contraction phase and later
reemerged in absence of any boost. The great majority of
vaccine-specific CD4+ and CD8+ T cells lacked IFN-γ pro-
duction but showed high Ag-specific proliferation capac-
ity. Proliferative CD8+ T cells expressed the lytic
Granzyme B. Contrasting to these data no antibody
response specific to HIV antigens was detected. This vacci-
nation strategy was not associated with any detectable
proviral integration in the PBMC of immunized animals.
Furthermore no autoantibody to DNA was detected in
sera of these animals.
Conclusion
Altogether, our comprehensive analysis demonstrated for
the first time the capacity of a single high dose of HIV
DNA vaccine alone to induce potent, long-lasting and
polyfunctional T cell responses in NHP.
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